Summary & Overview
HCPCS Level II J0400: Aripiprazole Injection, Intramuscular 0.25 mg
HCPCS Level II code J0400 denotes a 0.25 mg intramuscular injection of aripiprazole, an antipsychotic used in behavioral health care. This code matters nationally as it standardizes billing for a specific parenteral dose formulation, affecting facility charge capture, outpatient behavioral health services, and pharmacy administration workflows. Accurate use of J0400 supports consistent reimbursement and clinical documentation for injectable antipsychotic delivery.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for intramuscular aripiprazole use, typical sites of service where this administration occurs, and the implications for billing and claims processing. The publication summarizes available benchmarks, common billing modifiers, and payer coverage patterns where available. It also highlights policy considerations related to injectable psychiatric medications and notes when input data is not provided.
This summary is intended for revenue cycle managers, billing professionals, and clinical leaders seeking a concise reference for coding, site-of-service expectations, and payer landscape for intramuscular aripiprazole at the 0.25 mg dose.
Billing Code Overview
HCPCS Level II code J0400 represents an injection of aripiprazole, intramuscular, 0.25 mg. This code describes a specific administered dose of the antipsychotic medication aripiprazole formulated for intramuscular injection.
-
Service type: Medication administration (intramuscular injectable medication)
-
Typical site of service: Ambulatory clinic, outpatient behavioral health clinic, emergency department, or other facility settings where intramuscular injections are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with schizophrenia or schizoaffective disorder who presents to an outpatient behavioral health clinic or infusion center for a maintenance intramuscular antipsychotic injection. The clinician confirms treatment plan, documents informed consent and medication history, screens for recent adverse effects (extrapyramidal symptoms, metabolic issues), checks medication vial and dose, and verifies the injection site and supplies. A licensed nurse performs the intramuscular injection of J0400 (aripiprazole 0.25 mg per unit), documents lot number and site (deltoid or gluteal), monitors the patient for 15–30 minutes for acute reaction, records vital signs, and updates the patient's med administration record. Typical settings are outpatient behavioral health clinics, psychiatric clinics, hospital outpatient infusion centers, and skilled nursing facilities where intramuscular long‑acting antipsychotic management is provided.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies and standard billing for the injection is submitted |
22 |